Publication | Open Access
Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question—Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head
61
Citations
21
References
2020
Year
The addition of adjuvant erlotinib to gemcitabine did not provide a signal for increased OS in this trial.
| Year | Citations | |
|---|---|---|
Page 1
Page 1